These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3938057)

  • 1. [Natural history of anti-factor VIII antibodies in hemophilia A patients].
    Allain JP
    Rev Fr Transfus Immunohematol; 1985 Dec; 28(6):581-9. PubMed ID: 3938057
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoradiometric assay of VIII:CAg, a potential tool to detect human anti-VIII:C antibodies.
    Hellings JA; van Leeuwen FR; Over J; van Mourik JA
    Thromb Res; 1982 May; 26(4):297-302. PubMed ID: 6810499
    [No Abstract]   [Full Text] [Related]  

  • 3. Is oral tolerance therapy possible for haemophilia with inhibitors?
    Terada K; Yagi Y; Niizuma T; Kataoka N
    Vox Sang; 2001 Jan; 80(1):61-2. PubMed ID: 11339071
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of hemophilia A treatment: factor VIII inhibitors.
    Kasper CK
    Ann N Y Acad Sci; 1991; 614():97-105. PubMed ID: 1902643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemophilia A with factor VIII inhibitor].
    Shima M
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract]   [Full Text] [Related]  

  • 6. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Baglin T; Beacham E
    Thromb Haemost; 1998 Dec; 80(6):1036-7. PubMed ID: 9869186
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor VIII:C inhibitor associated with monoclonal-antibody purified FVIII concentrate.
    Kessler CM; Sachse K
    Lancet; 1990 Jun; 335(8702):1403. PubMed ID: 1971683
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-factor-VIII inhibitors in haemophilia.
    Lancet; 1989 Aug; 2(8659):363-4. PubMed ID: 2569554
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation.
    Zerra PE; Arthur CM; Chonat S; Maier CL; Mener A; Shin S; Allen JWL; Baldwin WH; Cox C; Verkerke H; Jajosky RP; Tormey CA; Meeks SL; Stowell SR
    Front Immunol; 2020; 11():905. PubMed ID: 32582142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].
    Wu RH; Wei QQ
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):631-4. PubMed ID: 24225299
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.
    Hay CR; Ollier W; Pepper L; Cumming A; Keeney S; Goodeve AC; Colvin BT; Hill FG; Preston FE; Peake IR
    Thromb Haemost; 1997 Feb; 77(2):234-7. PubMed ID: 9157572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient inhibitors in the Recombinate PUP study.
    Rothschild C; Gill J; Scharrer I; Bray G
    Thromb Haemost; 2000 Jul; 84(1):145-6. PubMed ID: 10928491
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of factor VIII antibodies.
    Shapiro SS
    Ann N Y Acad Sci; 1975 Jan; 240():350-61. PubMed ID: 46139
    [No Abstract]   [Full Text] [Related]  

  • 15. The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.
    Fijnvandraat K; Turenhout EA; van den Brink EN; ten Cate JW; van Mourik JA; Peters M; Voorberg J
    Blood; 1997 Jun; 89(12):4371-7. PubMed ID: 9192760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.
    Allain JP; Frommel D
    Blood; 1974 Sep; 44(3):313-22. PubMed ID: 4604102
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII haplotypes in severe hemophilia A patients in India.
    Pinto P; Ghosh K; Shetty S
    Ann Hematol; 2013 Jul; 92(7):999-1000. PubMed ID: 23262994
    [No Abstract]   [Full Text] [Related]  

  • 18. Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran.
    Modaresi AR; Torghabeh HM; Pourfathollah AA; Shooshtari MM; Yazdi ZR
    Hematology; 2006 Jun; 11(3):215-7. PubMed ID: 17325965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies.
    Hach-Wunderle V; Teixidor D; Zumpe P; Kühnl P; Scharrer I
    Infusionstherapie; 1989 Jun; 16(3):100-1. PubMed ID: 2503450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to develop factor VIII antibody in classic hemophilia.
    Frommel D; Allain JP
    Clin Immunol Immunopathol; 1977 Jul; 8(1):34-8. PubMed ID: 880746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.